New Oral AntiCoagulants Use in REnal Disease and AF (NOACURE-AF) Where do we stand?: An expert consensus view using the Delphi method

Turk Kardiyol Dern Ars. 2021 Jul;49(5):345-352. doi: 10.5543/tkda.2021.40652.
No abstract available

Publication types

  • Consensus Statement

MeSH terms

  • Administration, Oral
  • Antifibrinolytic Agents / therapeutic use
  • Antithrombins / administration & dosage*
  • Atrial Fibrillation / complications*
  • Delphi Technique*
  • Diabetes Complications
  • Heart Failure / complications
  • Humans
  • Hypertension / complications
  • Kidney Failure, Chronic / complications
  • Renal Dialysis / adverse effects
  • Renal Insufficiency, Chronic / complications*
  • Renal Insufficiency, Chronic / therapy
  • Risk Factors
  • Stroke / etiology*
  • Vascular Diseases / complications
  • Warfarin / therapeutic use

Substances

  • Antifibrinolytic Agents
  • Antithrombins
  • Warfarin